Request More Information Contact the Seller
- RE: SaaS AI Platform For Trial Optimization
- Contact: Rick Carlson
- License #: 1820673
Quick Facts
| Asking Price: | Not Disclosed | |
| Annual Revenue: | $10,677 | |
| Net Profit: | Not Disclosed | |
| Cash Flow: | $4,521 | |
| Total Debt: | Not Disclosed | |
| FF&E: | Not Disclosed | |
| Real Estate: | Not Disclosed | |
| Year Established: | 2024 | |
| Employees: | 6 | |
| BBN Listing #: | 1002862 | |
| Broker Reference #: | 1454 AI |
Business Overview:
Our client has built a revolutionary Predictive Digital Twin platform transforming the clinical trial industry through AI-driven prognostic modeling. Founded by a Harvard-trained physician-scientist and robotics engineer, our client addresses the multibillion-dollar problem of patient recruitment and retention failures in pharmaceutical trials.
Using Federated Learning and a proprietary Self-Correcting Transformer (SCT) engine, our client integrates real-time clinical, molecular, and biosensor data to predict Enrollment Quality, Adherence Probability, and Therapeutic Response for each participant. This ensures the right patient is matched with the right trial — accelerating development timelines and reducing costs for sponsors.
NDA required to receive comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
Contact the Seller:
To request more information regarding this listing, simply check the ADD TO REQUEST INFO BASKET button (above Quick Facts) and when you are done searching and have made all your selections, simply click on the REQUEST FREE INFO button at the bottom of this page.
Property Features and Assets:
Home based business, portable.
Market Competition and Expansion:
Competition: None have this revolutionary technology.
Growth & Expansion: The company employs a Hybrid SaaS revenue model with recurring clinical site subscriptions and enterprise success fees from large pharmaceutical partners. The company is on the cusp of rapid growth but cannot do so on its own balance sheet presently to service customers already wanting to do business with the Company. 2026 will be $.3M, year 3 is projected to be > $10M, year 5 is projected to be > $50M in revenue.
With secured clinical partnerships and technical collaborations with AI and data science experts, our client is positioned for exponential scale in the $60B+ clinical research market.
Reason for Selling:
Find a growth partner to finalize MVP commercialization and expand enterprise adoption. Kindly ask the seller for more information.
Additional Details:
- The property is Leased.
- The owner is willing to train/assist the new owner.
- This is not homebased business opportunity.
- This is not a franchise resale opportunity
Documents:
Relevant Links:
- View more Georgia businesses for sale
- View more Businesses For Sale in the same industry
- Sell a business online
- Find a business broker
Request More Information
